Subsequently, Yoon et al. conducted a study in which recombinant Lactobacillus casei secreting α-MSH was orally administered to mice with DSS-induced colitis, resulting in the alleviation of acute colitis-related indicators (i.e., histological activity, weight loss, and MPO activity). Here, STAMBP is linked to colitis.